14th Sep 2020 19:10
Phimedix PLC - cash shell - Trading in shares temporarily suspended under AIM rule 15, which requires companies to make an acquisition or acquisitions constituting a reverse takeover within six months of becoming a cash shell. Phimedix disposed of main operating subsidiary Masterpiece back in March and is in early stage talks to find a reverse acquisition. AIM could cancel Phimedix's listing in six months' time should no acquisition be made.
Current stock price: 0.94 pence
Year-to-date change: up 58%
By Anna Farley; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
PHM.L